Stereotactic ablative radiotherapy for patients with hepatocellular carcinoma: analysis of post-treatment radiology and explant histology
Abstract Background Stereotactic ablative radiotherapy (SABR) has emerged as a new treatment modality for hepatocellular carcinoma (HCC). Evaluation of tumour responses following SABR are currently based on conventional radiological criteria used for locoregional therapies. Whether these criteria ac...
Saved in:
| Main Authors: | Nekisa Zakeri, Ramanivas Sundareyan, Owen Cain, James Good, Tahir Shah, Shishir Shetty |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | BJC Reports |
| Online Access: | https://doi.org/10.1038/s44276-025-00136-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of artificial intelligence in stereotactic ablative body radiotherapy for hepatocellular carcinoma
by: Atsuto Katano
Published: (2025-06-01) -
Retrospective Comparative Study to Assess the Safety and Efficacy of Transradial Arterial Access for Hepatic Tumor Embolizations: A Single Operator Experience
by: Ramanivas Sundareyan, et al.
Published: (2023-01-01) -
Ablative Techniques for Lung Metastases: Patient Selection and Outcomes Following Treatment with Stereotactic Radiotherapy or Radiofrequency Ablation
by: Jennifer W. S. Pang, et al.
Published: (2025-05-01) -
Establishing the Role of Stereotactic Ablative Body Radiotherapy in Early-Stage Breast Cancer
by: Aisling Barry, et al.
Published: (2018-01-01) -
Stereotactic total ablative radiotherapy with MR-LINAC for synchronous oligometastatic prostate cancer
by: Darren MC. Poon, et al.
Published: (2025-07-01)